EMIS Emis Group Plc

TIDMEMIS

RNS Number : 3599K

EMIS Group PLC

05 May 2022

5 May 2022

EMIS Group plc

("EMIS Group" or "the Group")

AGM Statement

Ahead of its AGM being held later today, EMIS Group, the UK leader in connected healthcare software and systems, issues the following update on trading.

The Board of EMIS Group is pleased to announce that trading for the year to date is in line with the Board's expectations.

As reported on 17 March 2022 at the time of its 2021 Full Year Results, the Group continues to have leading positions in specialist markets, benefits from high levels of recurring revenue and remains in a strong financial position, with a robust pipeline of potential new business, investment and acquisition opportunities for 2022 and beyond.

The two acquisitions completed in the year so far (Edenbridge and FourteenFish) are performing well, with integration progressing on plan and new market opportunities emerging as expected.

The Group continues to invest in its technology and cloud refresh strategy as well as in improved internal systems. These projects are expected to drive greater efficiencies in the coming years.

Andy Thorburn, Chief Executive Officer of EMIS Group, said:

"The Board is pleased to report a good start to trading in 2022 and believes the Group continues to be very well placed to deliver greater insight, efficiency and integration in healthcare for the benefit of our customers across the NHS and private sectors."

Enquiries:

For further information, contact:

EMIS Group plc Tel: 0330 024 1269

Andy Thorburn, CEO

Peter Southby, CFO

www.emisgroupplc.com

@EMISGroup

   Numis Securities Limited (Nominated Adviser & Broker)            Tel: 020 7260 1000 

Josh Hughes/Simon Willis/James Black

MHP Communications Tel: 020 3128 8567

   Reg Hoare/James Bavister/Matthew Taylor/Pauline Guenot            emis@mhpc.com 

Notes to Editors

EMIS Group is the UK leader in connected healthcare software and systems. Its solutions are widely used across every major UK healthcare setting. EMIS Group's aim is to join up healthcare through innovative technology, helping to deliver better health outcomes to the UK population, supporting longer and healthier lives.

EMIS Group has two core business segments: EMIS Health and EMIS Enterprise.

EMIS Health is a supplier of innovative integrated care technology to the NHS, including primary, community, acute and social care.

EMIS Enterprise is focussed on growth in the business-to-business technology sector within the healthcare market, including management of medicines, partner businesses, patient-facing services, data and analytics, and research and life sciences.

LEI: 213800K474ZZK76NX913

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

AGMFZGGKVDRGZZM

(END) Dow Jones Newswires

May 05, 2022 02:00 ET (06:00 GMT)

Emis (LSE:EMIS)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Emis (LSE:EMIS)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024